Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Analysts Maintain Average "Hold" Rating on LyondellBasell Industries (NYSE: LYB) with Mixed Price Targets

LyondellBasell Industries N.V. (NYSE: LYB) has received an average recommendation of "Hold" from fourteen brokerages covering the stock, according to MarketBeat. Of these, two analysts have assigned a "sell" rating, nine have issued a "hold," two have rated the stock a "buy," and one …

Aditi Sarkar | 04 September 2025

Stocks Struggle, Commodities Mixed, and Tariff Battle Intensifies

Index Update:U.S. stocks opened September on a weak note, with the Dow down 0.6%, the S&P 500 off 0.7%, and the Nasdaq lower by 0.8%, while the Cboe Volatility Index edged higher. Alphabet shares surged over 5% premarket after a favorable antitrust ruling, boosting …

Team Kalkine | 03 September 2025

Great Elm Group (NASDAQ: GEG) Delivers Record Q4 Net Income and Expands AUM

Great Elm Group (NASDAQ: GEG) reported its brightest operating year to date, delivering record financial results for the fourth quarter (Q4) and fiscal year 2025. The company posted Q4 net income from continuing operations of AUD 15.7 million, a significant turnaround from the prior-year …

Team Kalkine | 03 September 2025

ORIX Corporation USA (NYSE: IX) Finalizes Majority Acquisition of Hilco Global

ORIX Corporation USA (NYSE: IX) has completed its acquisition of a majority stake in Hilco Global, a diversified financial services firm known for its asset valuation, advisory, and capital solutions businesses. Following the transaction, Hilco Global will operate as a subsidiary of ORIX USA, …

Team Kalkine | 03 September 2025

DXC Technology (NYSE: DXC) Expands AI Collaborations with Acumino, CAMB.AI, and GreenMatterAI

DXC Technology (NYSE: DXC) has announced a series of strategic AI collaborations under its STARTUP AUTOBAHN partnership, teaming up with Acumino, CAMB.AI, and GreenMatterAI to scale applied innovation for enterprise clients. The company has evaluated over 100 emerging technology startups and successfully launched more …

Team Kalkine | 03 September 2025

Mister Car Wash (NYSE: MCW) Earns Consensus “Hold” Rating from Analysts

Mister Car Wash, Inc. (NYSE: MCW) has received an average rating of “Hold” from twelve research firms currently covering the stock, according to MarketBeat.com. The consensus reflects one analyst assigning a sell rating, five maintaining a hold, and six giving buy recommendations. The average …

Aditi Sarkar | 02 September 2025

British American Tobacco (NYSE: BTI) Earns “Moderate Buy” Consensus Rating from Analysts

Shares of British American Tobacco p.l.c. (NYSE: BTI) have been given a consensus rating of “Moderate Buy” by five research firms currently tracking the company, according to Marketbeat. The rating distribution reflects one analyst issuing a sell recommendation and four maintaining buy ratings. The …

Aditi Sarkar | 02 September 2025

Tuya Inc.’s (NYSE: TUYA) Net Income Soars 302% in Q2FY25, Board Declares USD 33Mn Dividend Payout

Tuya Inc. (NYSE: TUYA)provides Internet of Things (IoT) cloud development platforms and services. The company’s board has approved a cash dividend of USD 0.054 per ordinary share/ADS. This is equivalent to an aggregate payout of approximately USD 33 million.

Aditi Sarkar | 02 September 2025

US Markets Retreat After Labor Day: Stocks Decline, Commodities Surge Amid Rate Cut Anticipation

Performance of Broader Market Indices:On September 2, 2025, the US market ended lower, with the Dow Jones Industrial Average down 0.2% at 45,544.88, the S&P 500 declining 0.6% to 6,460.26, and the Nasdaq Composite retreating 1.2% to 21,455.55. The weakness followed profit-taking in tech …

Team Kalkine | 02 September 2025

Zai Lab (NASDAQ: ZLAB) Gains Hong Kong Approval for TIVDAK Cervical Cancer Therapy

Zai Lab Limited (NASDAQ: ZLAB) announced that Hong Kong’s Department of Health has approved TIVDAK (tisotumab vedotin-tftv), its antibody-drug conjugate (ADC) therapy for adult patients with recurrent or metastatic cervical cancer who experienced disease progression during or after chemotherapy. This marks an important regulatory …

Team Kalkine | 01 September 2025
Support

Hi! How can we help you today?

Loading…